Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 49
Filter
1.
J Microsc ; 279(3): 242-248, 2020 09.
Article in English | MEDLINE | ID: mdl-32157689

ABSTRACT

Liquid phase transmission electron microscopy allows the imaging of materials in liquid environments. The sample is encapsulated within electron-beam transparent windows and hence protected by the ultrahigh vacuum necessary within the electron gun. Such an approach allows to study biological and soft materials in their natural environment and offers the possibility of accessing their dynamic nature. Yet, the electron beam scattering from the windows and solvent increases the image noise and blur. Herein, we propose a pipeline to both de-noise and sharpen images obtained by liquid transmission electron microscopy. We develop the workflow in a way that it does not require any human interference, nor introduce artefacts, but actually unveils features of the imaged samples covered by the noise and the blur. LAY DESCRIPTION: Transmission Electron Microscopy TEM is one of the most powerful techniques for structural determination at the nanoscale, with the ability to image matter down to the atomic level. TEM is only possible by keeping the electron beam under high vacuum in order to avoid undesired scattering events in the beam path. High vacuum means that the TEM samples must conventionally be in solid-state. Thus, samples in liquid form or containing liquids, like water, need special preparation techniques which tend to alter the structure and chemical nature of the sample. Such alterations are particularly critical for biological and soft organic materials where the structures are controlled by the presence of water and/or other liquids. The development of new cameras, materials and sample holders have made possible for TEM to be performed on liquid samples. Liquid Phase Transmission Electron Microscopy (LTEM) offers the possibility to investigate nanoscopic structures in liquid state and monitor dynamic processes. However important limitations come from the liquid nature of samples in the imaging process such as the low contrast afforded by organic and biological materials and additional noise and blur introduced by the liquid sample and its thickness. Existing image analysis algorithms for TEM result inadequate for LTEM. The end-to-end image analysis method herein has the ability to recover the original images together with their sharpness, without introducing any artefacts. The proposed algorithms offer the great advantage of unveiling image details which are not usually seen during imaging, thus allowing a better understanding of the nature, structure and ultimately the function of the investigated structures. The fully automatised analysis method allows to efficiently process dozens of images in few hours, improving dramatically the performance of LTEM imaging.

2.
J Sports Sci ; 37(21): 2443-2451, 2019 Nov.
Article in English | MEDLINE | ID: mdl-31304885

ABSTRACT

The aim of this study was to identify the importance and meaning of goals using the goalkeeper as an outfield player in elite futsal according to critical and situational variables. The sample consisted of 11,446 actions corresponding to 1,325 matches from the 1st division Spanish Futsal League during the seasons from 2010 to 2015. Multinomial logistic regression and classification tree multivariate models were used to identify the best predictor variables related to the likelihood of scoring goals, receiving goals, or no goals. Results from Multinomial logistic regression emphasised goals scored in balanced matches and playing with the goalkeeper as an outfield player before the last eight minutes. When the teams were drawing or losing, finished with goals received or without goals. The classification tree results identified a greater likelihood of scoring goals when the teams were winning, in balanced matches, and within the last eight minutes. Conversely, a greater likelihood of suffering goals was observed using the goalkeeper as an outfield player when the teams were losing, in unbalanced matches and in the last eight minutes. The identified trends will allow futsal coaches to recognise the most suitable situations for achieving efficacy when using the goalkeeper as an outfield player strategy.


Subject(s)
Athletic Performance/physiology , Competitive Behavior/physiology , Soccer/physiology , Decision Trees , Humans , Multivariate Analysis , Spain , Time Factors
3.
An Pediatr (Barc) ; 66(3): 260-6, 2007 Mar.
Article in Spanish | MEDLINE | ID: mdl-17349252

ABSTRACT

BACKGROUND: According to the World Health Organization (WHO), goiter is endemic in Spain. The main cause of endemic goiter is iodine deficiency, which is also the principal cause of mental retardation and avoidable cerebral palsy throughout the world. MATERIAL AND METHODS: We conducted an observational study to determine the prevalence of endemic goiter and nutritional iodine status in the province of Alicante. Urinary iodine excretion was measured in a morning urine sample, and thyroid volume was measured by means of a thyroid ultrasound scan. A case of goiter was diagnosed if thyroid volume was above the 97th percentile adjusted by age, as published by the WHO. RESULTS: No cases of goiter were found. In addition, the median urinary iodine excretion levels adjusted by age were within the normal range, as defined by the WHO's criteria. CONCLUSIONS: Endemic goiter was not found in the province of Alicante and urinary iodine excretion values demonstrated adequate iodine intake. Further ultrasound studies are needed to establish reference thyroid volumes for our population.


Subject(s)
Goiter, Endemic/epidemiology , Iodine/deficiency , Nutritional Status , Catchment Area, Health , Child , Cross-Sectional Studies , Female , Goiter, Endemic/diagnosis , Goiter, Endemic/metabolism , Humans , Male , Prevalence , Spain/epidemiology
4.
Nucleic Acids Res ; 29(7): 1549-55, 2001 Apr 01.
Article in English | MEDLINE | ID: mdl-11266557

ABSTRACT

The intracellular pathogen Trypanosoma cruzi is the etiological agent of Chagas' disease. We have isolated a full-length cDNA encoding uracil-DNA glycosylase (UDGase), a key enzyme involved in DNA repair, from this organism. The deduced protein sequence is highly conserved at the C-terminus of the molecule and shares key residues involved in binding or catalysis with most of the UDGases described so far, while the N-terminal part is highly variable. The gene is single copy and is located on a chromosome of approximately 1.9 Mb. A His-tagged recombinant protein was overexpressed, purified and used to raise polyclonal antibodies. Western blot analysis revealed the existence of a single UDGase species in parasite extracts. Using a specific ethidium bromide fluorescence assay, recombinant T.cruzi UDGase was shown to specifically excise uracil from DNA. The addition of both Leishmania major AP endonuclease and exonuclease III, the major AP endonuclease from Escherichia coli, produces stimulation of UDGase activity. This activation is specific for AP endonuclease and suggests functional communication between the two enzymes.


Subject(s)
Carbon-Oxygen Lyases/metabolism , DNA Glycosylases , Escherichia coli Proteins , N-Glycosyl Hydrolases/genetics , Trypanosoma cruzi/enzymology , Amino Acid Sequence , Animals , Blotting, Western , Chromosome Mapping , DNA, Complementary/chemistry , DNA, Complementary/genetics , DNA, Complementary/isolation & purification , DNA-(Apurinic or Apyrimidinic Site) Lyase , Deoxyribonuclease IV (Phage T4-Induced) , Electrophoresis, Polyacrylamide Gel , Exodeoxyribonucleases/metabolism , Molecular Sequence Data , N-Glycosyl Hydrolases/metabolism , Sequence Alignment , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Trypanosoma cruzi/genetics , Uracil-DNA Glycosidase
5.
An Pediatr (Barc) ; 65(6): 619-22, 2006 Dec.
Article in Spanish | MEDLINE | ID: mdl-17194331

ABSTRACT

The weaning process is a critical phase in patients undergoing mechanical ventilation. This process can be hampered by numerous causes, such as neuromuscular diseases and spinal muscular atrophy (SMA). We present a 6-month-old boy with respiratory distress, fever, marked hypotonia without motor developmental milestones, and areflexia. The patient showed progressive respiratory distress requiring mechanical ventilation. Definitive weaning was not achieved and the boy died from respiratory failure. Partial autopsy was performed with a diagnosis of SMA and genetic study of the parents. Neuromuscular diseases are an infrequent cause of respiratory insufficiency in suckling infants. The differential diagnosis is made between axonal and motor neuron diseases. The diagnosis was confirmed by muscular biopsy and genetic study.


Subject(s)
Respiratory Insufficiency/therapy , Ventilator Weaning , Fatal Outcome , Humans , Infant , Male , Muscular Atrophy, Spinal/complications , Muscular Atrophy, Spinal/diagnosis , Respiratory Insufficiency/etiology , Treatment Failure
6.
Biochim Biophys Acta ; 1227(3): 188-94, 1994 Nov 29.
Article in English | MEDLINE | ID: mdl-7986827

ABSTRACT

We have selected for a Leishmania infantum cell line resistant to high levels of methotrexate (MTX). The resulting cells were 1233-fold more resistant than wild-type and contained amplified H-region circles. Homologous genes to the antifolate resistant ltdh gene and to the P-glycoprotein ltpgpA gene of Leishmania tarentolae were observed to be contained within the amplicon. In order to invoke additional mechanisms of resistance, we examined possible variations in MTX accumulation. Resistance was not correlated with a decreased uptake of MTX. On the contrary, the resistant line presented a 3-fold increase in the steady-state accumulation of drug with regard to the wild-type line. Northern blot analysis using gene specific probes, showed that the ltdh probe and the ltpgpA probe recognized single transcripts of 1 kb and 5 kb respectively which were both overexpressed only approx. 5-fold in resistant cells. We propose that amplification of the antifolate resistance gene, homologue to the ltdh gene of L. tarentolae, is apparently the only mechanism involved in resistance to the cytotoxic drug MTX in L. infantum resistant to 1000 microM of MTX.


Subject(s)
Genes, Protozoan , Leishmania infantum/genetics , Methotrexate/pharmacology , Animals , Drug Resistance/genetics , Gene Amplification , Leishmania infantum/drug effects
7.
J Biomol Screen ; 20(1): 82-91, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25332350

ABSTRACT

African trypanosomiasis, leishmaniasis, and Chagas disease are 3 neglected tropical diseases for which current therapeutic interventions are inadequate or toxic. There is an urgent need to find new lead compounds against these diseases. Most drug discovery strategies rely on high-throughput screening (HTS) of synthetic chemical libraries using phenotypic and target-based approaches. Combinatorial chemistry libraries contain hundreds of thousands of compounds; however, they lack the structural diversity required to find entirely novel chemotypes. Natural products, in contrast, are a highly underexplored pool of unique chemical diversity that can serve as excellent templates for the synthesis of novel, biologically active molecules. We report here a validated HTS platform for the screening of microbial extracts against the 3 diseases. We have used this platform in a pilot project to screen a subset (5976) of microbial extracts from the MEDINA Natural Products library. Tandem liquid chromatography-mass spectrometry showed that 48 extracts contain potentially new compounds that are currently undergoing de-replication for future isolation and characterization. Known active components included actinomycin D, bafilomycin B1, chromomycin A3, echinomycin, hygrolidin, and nonactins, among others. The report here is, to our knowledge, the first HTS of microbial natural product extracts against the above-mentioned kinetoplastid parasites.


Subject(s)
Antiprotozoal Agents/pharmacology , Biological Products/pharmacology , Drug Discovery/methods , High-Throughput Screening Assays/methods , Leishmania/drug effects , Trypanosoma brucei gambiense/drug effects , Trypanosoma cruzi/drug effects , Animals , Antiprotozoal Agents/therapeutic use , Biological Products/therapeutic use , Chagas Disease/drug therapy , Dose-Response Relationship, Drug , Drug Discovery/standards , High-Throughput Screening Assays/standards , Humans , Inhibitory Concentration 50 , Leishmaniasis/drug therapy , Neglected Diseases/drug therapy , Trypanosomiasis, African/drug therapy
8.
Protein Sci ; 10(7): 1426-33, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11420444

ABSTRACT

Kinetic properties of the dimeric enzyme dUTPase from Leishmania major were studied using a continuous spectrophotometric method. dUTP was the natural substrate and dUMP and PPi the products of the hydrolysis. The trypanosomatid enzyme exhibited a low K(m) value for dUTP (2.11 microM), a k(cat) of 49 s(-1), strict Michaelis-Menten kinetics and is a potent catalyst of dUDP hydrolysis, whereas in other dUTPases described, this compound acts as a competitive inhibitor. Discrimination is achieved for the base and sugar moiety showing specificity constants for different dNTPs similar to those of bacterial, viral, and human enzymes. In the alkaline range, the K(m) for dUTP increases with the dissociation of ionizable groups showing pK(a) values of 8.8, identified as the uracil moiety of dUTP and 10, whereas in the acidic range, K(m) is regulated by an enzyme residue exhibiting a pK(a) of 7.1. Activity is strongly inhibited by the nucleoside triphosphate analog alpha-beta-imido-dUTP, indicating that the enzyme can bind triphosphate analogs. The existence of specific inhibition and the apparent structural and kinetic differences (reflected in different binding strength of dNTPs) with other eukaryotic dUTPases suggest that the present enzyme might be exploited as a target for new drugs against leishmaniasis.


Subject(s)
Leishmania major/enzymology , Pyrophosphatases/antagonists & inhibitors , Pyrophosphatases/chemistry , Animals , Cations/pharmacology , Deoxyuracil Nucleotides/metabolism , Dimerization , Hydrogen-Ion Concentration , Kinetics , Pyrophosphatases/metabolism , Substrate Specificity , Temperature
9.
Mol Biochem Parasitol ; 76(1-2): 175-85, 1996.
Article in English | MEDLINE | ID: mdl-8920005

ABSTRACT

We have cloned and expressed in Escherichia coli a 702-base pair gene coding for the dihydrofolate reductase (DHFR) domain of the bifunctional dihydrofolate reductase-thymidylate synthase (DHFR-TS) from Trypanosoma cruzi. The DHFR domain was purified to homogeneity by methotrexate-Sepharose chromatography followed by an anion-exchange chromatography step in a mono Q column, and displayed a single 27-kDa band on SDS-PAGE. Gel filtration showed that the catalytic domain was expressed as a monomer. Kinetic parameters were similar to those reported for the wild-type bifunctional enzyme with Km values of 0.75 microM for dihydrofolate and 16 microM for NADPH and a kcat value of 16.5 s-1. T. cruzi DHFR is poorly inhibited by trimethoprim and pyrimethamine and the inhibition constants were always lower for the bifunctional enzyme. The binding of methotrexate was characteristic of a class of inhibitors that form an initial complex which isomerizes slowly to a tighter complex and are referred to as 'slow, tight-binding' inhibitors. While the slow-binding step of inhibition was apparently unaffected in the individually expressed DHFR domain, the overall inhibition constant was two-fold higher as a consequence of the superior inhibition constant value obtained for the initial inhibitory complex.


Subject(s)
Genes, Protozoan , Tetrahydrofolate Dehydrogenase/chemistry , Trypanosoma cruzi/enzymology , Animals , Base Sequence , Cloning, Molecular , Gene Expression , Methotrexate/antagonists & inhibitors , Molecular Sequence Data , Pyrimethamine/antagonists & inhibitors , Tetrahydrofolate Dehydrogenase/genetics , Tetrahydrofolate Dehydrogenase/metabolism , Trimethoprim/antagonists & inhibitors , Trypanosoma cruzi/genetics
10.
Mol Biochem Parasitol ; 65(2): 247-58, 1994 Jun.
Article in English | MEDLINE | ID: mdl-7969266

ABSTRACT

We have cloned, sequenced and expressed the Trypanosoma cruzi gene encoding the bifunctional protein dihydrofolate reductase-thymidylate synthase (DHFR-TS). The strategy followed for the isolation of positive clones from a genomic library was based on the construction of a probe by the amplification of highly conserved sequences of the TS domain by the polymerase chain reaction. Translation of the open reading frame of 1563 bp yields a polypeptide of 521 amino acids with a molecular mass of 58829 Da. For heterologous expression of T. cruzi DHFR-TS in Escherichia coli, the entire coding sequence was amplified by polymerase chain reaction and cloned into the plasmid vector pKK223.3. The presence of catalytically active DHFR-TS was demonstrated by complementation of the Thy- E. coli strain chi 2913 and the DHFR- Thy- E. coli strain PA414. The gene is expressed as an active protein which constitutes approximately 2% of the total cell soluble protein. Recombinant bifunctional enzyme and the DHFR domain have been purified by methotrexate-Sepharose chromatography to yield 1-2 mg of active DHFR-TS per litre of culture. Southern and electrophoretic analyses using the coding sequence as probe indicated that the T. cruzi enzyme is encoded by a single copy gene which maps to two bands of approximately 990 kb and 1047 kb. It appears that T. cruzi is diploid for the DHFR-TS gene which is located on two different-sized homologous chromosomes.


Subject(s)
Gene Expression Regulation, Enzymologic , Tetrahydrofolate Dehydrogenase/genetics , Thymidylate Synthase/genetics , Trypanosoma cruzi/enzymology , Amino Acid Sequence , Animals , Base Sequence , Cloning, Molecular , DNA, Protozoan/analysis , Escherichia coli/enzymology , Escherichia coli/genetics , Genes, Protozoan , Molecular Sequence Data , Oligonucleotides , Polymerase Chain Reaction , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Sequence Homology, Amino Acid , Tetrahydrofolate Dehydrogenase/isolation & purification , Tetrahydrofolate Dehydrogenase/metabolism , Thymidylate Synthase/isolation & purification , Thymidylate Synthase/metabolism
11.
Mol Biochem Parasitol ; 93(2): 191-202, 1998 Jun 01.
Article in English | MEDLINE | ID: mdl-9662704

ABSTRACT

Rat uncoupling protein 1 (UCP1) was successfully translated in transfected Leishmania major promastigotes. Immune electron microscopy revealed that the protein was exclusively in the mitochondria. UCP1 expression was about 350,000 copies per promastigote, accounting for 4.7% of the total mitochondrial protein. In intact parasites, expression of UCP1 induced a slight increase in respiratory rate and a modest decrease in mitochondrial membrane potential (delta psi(m)). In contrast, in digitonin-permeabilized parasites, a significantly lower value both in delta psi(m) (57 +/- 10 vs 153 +/- 12 mV) and respiratory control ratio (0.99 vs 1.54) were observed for UCP1 versus control parasites, although when UCP1 activity was inhibited by bovine serum albumin (BSA) and GDP, control values were restored. Therefore, a fully functional UCP1 was present and only partially inhibited in vivo by endogenous purine nucleotides. However, neither ATP levels, growth rate nor mitochondrial protein import differed significantly between both types of parasites. Expression of the pore-like mutant UCP1 delta 9 was deleterious to the organism. Consequently, Leishmania was capable of expressing and importing into mitochondria proteins from higher eukaryotes lacking an N-terminal targeting pre-sequence as UCP1. As described previously, parasite metabolism had only a limited tolerance to mitochondrial disfunction. Transfection of Leishmania with foreign proteins which play an important regulatory role in metabolism is a useful tool to study both parasite metabolism in general, and alternative pathways involved in maintaining internal homeostasis.


Subject(s)
Carrier Proteins/genetics , Carrier Proteins/metabolism , Leishmania major/metabolism , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mitochondria/metabolism , Adipose Tissue, Brown/chemistry , Animals , Carrier Proteins/biosynthesis , Gene Expression Regulation , Genetic Vectors , Guanosine Diphosphate/pharmacology , Hydrogen-Ion Concentration , Ion Channels , Isocitrate Dehydrogenase/metabolism , Leishmania major/genetics , Leishmania major/growth & development , Membrane Potentials , Membrane Proteins/biosynthesis , Mitochondrial Proteins , Oxygen Consumption , Plasmids , Rats , Recombinant Proteins/biosynthesis , Recombinant Proteins/metabolism , Transcription, Genetic , Transfection , Uncoupling Protein 1
12.
J Med Chem ; 42(21): 4300-12, 1999 Oct 21.
Article in English | MEDLINE | ID: mdl-10543874

ABSTRACT

This paper concerns the design, synthesis, and evaluation of inhibitors of leishmanial and trypanosomal dihydrofolate reductase. Initially study was made of the structures of the leishmanial and human enzyme active sites to see if there were significant differences which could be exploited for selective drug design. Then a series of compounds were synthesized based on 5-benzyl-2, 4-diaminopyrimidines. These compounds were assayed against the protozoan and human enzymes and showed selectivity for the protozoan enzymes. The structural data was then used to rationalize the enzyme assay data. Compounds were also tested against the clinically relevant forms of the intact parasite. Activity was seen against the trypanosomes for a number of compounds. The compounds were in general less active against Leishmania. This latter result may be due to uptake problems. Two of the compounds also showed some in vivo activity in a model of African trypanosomiasis.


Subject(s)
Folic Acid Antagonists/chemical synthesis , Tetrahydrofolate Dehydrogenase/metabolism , Trypanocidal Agents/chemical synthesis , Animals , Drug Design , Folic Acid Antagonists/chemistry , Folic Acid Antagonists/pharmacology , Humans , In Vitro Techniques , Leishmania infantum/drug effects , Leishmania infantum/enzymology , Leishmania major/drug effects , Leishmania major/enzymology , Macrophages, Peritoneal/parasitology , Mice , Models, Molecular , Tetrahydrofolate Dehydrogenase/chemistry , Trypanocidal Agents/chemistry , Trypanocidal Agents/pharmacology , Trypanosoma brucei brucei/drug effects , Trypanosoma brucei brucei/enzymology , Trypanosoma cruzi/drug effects , Trypanosoma cruzi/enzymology , Trypanosomiasis, African/drug therapy
13.
Eur J Med Chem ; 36(5): 395-405, 2001 May.
Article in English | MEDLINE | ID: mdl-11451529

ABSTRACT

There is an urgent need for the development of new drugs to treat Chagas' disease, which is caused by the protozoan parasite Trypanosoma cruzi. The enzyme dihydrofolate reductase (DHFR) has been a very successful drug target in a number of diseases and we decided to investigate it as a potential drug target for Chagas' disease. A homology model of the enzyme was used to search the Cambridge Structural Database using the program DOCK 3.5. Compounds were then tested against the enzyme and the whole parasite. Compounds were also screened against the related parasite, Trypanosoma brucei.


Subject(s)
Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Tetrahydrofolate Dehydrogenase/metabolism , Trypanosoma cruzi/drug effects , Trypanosoma cruzi/enzymology , Animals , Cell Line , Chagas Disease/drug therapy , Chagas Disease/parasitology , Databases as Topic , Disease Models, Animal , Drug Design , Drug Evaluation, Preclinical , Enzyme Inhibitors/therapeutic use , Folic Acid Antagonists/chemistry , Folic Acid Antagonists/pharmacology , Folic Acid Antagonists/therapeutic use , Inhibitory Concentration 50 , Mice , Muscles/cytology , Rats , Trypanosoma brucei rhodesiense/drug effects
14.
J Parasitol ; 73(2): 272-7, 1987 Apr.
Article in English | MEDLINE | ID: mdl-2438397

ABSTRACT

The present report deals with the alterations produced by cis-diamminedichloroplatinum (II) (DDP), and 2 of its analogs: cis-Pt(II)(tranylcypromine)2Cl2 and cis-Pt(II)(benzothiazole)2Cl2 in cultured epimastigote forms of Trypanosoma cruzi. Studies have been performed at the ultrastructural level and the inhibitory effect of these complexes on macromolecule synthesis, evaluated by 3H-thymidine, 3H-uridine, and 3H-leucine incorporation, has been investigated. DDP at concentrations of 50 and 100 micrograms/ml does not inhibit significantly the incorporation of radioactive precursors, but a clear decrease was observed with the 2 analogs. Eight hours of treatment at a concentration of 10 micrograms/ml rendered in all 3 cases an increase in autophagic vacuoles and lipids as well as an abnormal condensation of the nucleus chromatin.


Subject(s)
Cisplatin/analogs & derivatives , Cisplatin/pharmacology , Thiazoles/pharmacology , Tranylcypromine/analogs & derivatives , Trypanosoma cruzi/drug effects , Animals , Benzothiazoles , Cell Nucleus/ultrastructure , DNA/biosynthesis , DNA/drug effects , Leucine/metabolism , Microscopy, Electron , Organoids/ultrastructure , Protein Biosynthesis , RNA/biosynthesis , Thymidine/metabolism , Tranylcypromine/pharmacology , Trypanosoma cruzi/metabolism , Trypanosoma cruzi/ultrastructure , Uridine/metabolism , Vacuoles/ultrastructure
15.
Farmaco ; 44(11): 1095-107, 1989 Nov.
Article in English | MEDLINE | ID: mdl-2701965

ABSTRACT

The synthesis and the antiparasitic evaluation of twelve new 5-nitroimidaole derivatives has been carried out. The most effective compounds were the less hydrophilic pyridinium and imidazolium salts (IV), (V) and (X), and above all the tetrahydropyridine derivatives (XII) and (XIII).


Subject(s)
Nitroimidazoles/chemical synthesis , Animals , Anthelmintics/chemical synthesis , Antifungal Agents/chemical synthesis , Antimalarials/chemical synthesis , Chemical Phenomena , Chemistry , Entamoeba/drug effects , Giardia/drug effects , Magnetic Resonance Spectroscopy , Mice , Microbial Sensitivity Tests , Nitroimidazoles/pharmacology , Trichomonas/drug effects , Trichomonas vaginalis/drug effects , Trypanocidal Agents/chemical synthesis
16.
An Pediatr (Barc) ; 58(3): 273-6, 2003 Mar.
Article in Spanish | MEDLINE | ID: mdl-12628101

ABSTRACT

Primary cardiac tumors are uncommon with an estimated incidence of between 0.0017 % and 0.19 %. Most are benign. Whereas myxomas are the most common primary tumor in adults, in children they are exceptionally rare. Cardiac myxomas usually develop in the left atrium, 20 % occur in the right atrium and the remainder develops in the ventricles and rarely in the heart valves. Cerebrovascular strokes secondary to myxoma are rare in childhood. The diagnostic test of choice is transesophageal echocardiogram and early excision is the most effective treatment in preventing serious complications. We report a case of cerebral stroke as the only manifestation of an atrial myxoma in an 11-year-old-girl. The patient presented vertigo, right hemiparesis of the body and dysarthria without loss of consciousness. After diagnostic tests (computerized tomography, magnetic resonance imaging and cerebral angioresonance) she was diagnosed with an ischemic lesion in the left middle cerebral artery. Various investigations were performed to find the cause of the stroke, among them cardiologic study, and a mass in the left atrium suggestive of myxoma was found. The tumor was removed and the diagnosis of myxoma was confirmed by histopathological examination. Outcome was satisfactory. The presence of a cerebral ischemic episode, with or without concomitant heart disease, suggests the need to look for cardiac etiology.


Subject(s)
Heart Atria , Heart Neoplasms/complications , Myxoma/complications , Stroke/etiology , Child , Female , Humans
SELECTION OF CITATIONS
SEARCH DETAIL